| 查看: 298 | 回复: 1 | |||
[资源]
【转帖】MicriRNA-29对肝细胞癌凋亡、致瘤性和预后的影响
|
|
Effects of MicroRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma Based on microarray data, we have previously shown a significant down-regulation of miR-29 in hepatocellular carcinoma (HCC) tissues. To date, the role of miR-29 deregulation in hepatocarcinogenesis and the signaling pathways by which miR-29 exerts its function and modulates the malignant phenotypes of HCC cells remain largely unknown. In this study, we confirmed that reduced expression of miR-29 was a frequent event in HCC tissues using both Northern blot and real-time quantitative reverse-transcription polymerase chain reaction. More interestingly, we found that miR-29 down-regulation was significantly associated with worse disease-free survival of HCC patients. Both gain- and loss-of-function studies revealed that miR-29 could sensitize HCC cells to apoptosis that was triggered by either serum starvation and hypoxia or chemotherapeutic drugs, which mimicked the tumor growth environment in vivo and the clinical treatment. Moreover, introduction of miR-29 dramatically repressed the ability of HCC cells to form tumor in nude mice. Subsequent investigation characterized two antiapoptotic molecules, Bcl-2 and Mcl-1, as direct targets of miR-29. Furthermore, silencing of Bcl-2 and Mcl-1 phenocopied the proapoptotic effect of miR-29, whereas overexpression of these proteins attenuated the effect of miR-29. In addition, enhanced expression of miR-29 resulted in the loss of mitochondrial potential and the release of cytochrome c to cytoplasm, suggesting that miR-29 may promote apoptosis through a mitochondrial pathway that involves Mcl-1 and Bcl-2. Conclusion: Our data highlight an important role of miR-29 in the regulation of apoptosis and in the molecular etiology of HCC, and implicate the potential application of miR-29 in prognosis prediction and in cancer therapy. (HEPATOLOGY 2010.) |
回复此楼» 猜你喜欢
CSC银行卡避雷
已经有12人回复
-
项目没中，但到现在还没收到反馈意见，网上系统也查不到
已经有23人回复
-
放射医学论文润色/翻译怎么收费?
已经有294人回复
-
凉了，国合查不到。
已经有12人回复
-
本科浙大临床医学317求调剂
已经有5人回复
» 本主题相关价值贴推荐，对您同样有帮助:
- 求助细胞凋亡有关的问题
已经有9人回复
- 肿瘤靶向
已经有16人回复
- 静脉注射药物经过多长时间能进入肝细胞
已经有3人回复
- 自噬与凋亡？
已经有7人回复
- 我就不信这么好的帖子 在这里火不了 中国研发“饿死”肿瘤抗癌新药 完成二期临床
已经有23人回复
- 省电灯泡会致癌 空气须流通
已经有4人回复
- 【交流】原代肝细胞培养
已经有13人回复
- 【交流】抗肿瘤药物配成溶液后的保存时间
已经有9人回复
- 【分享转载】家居养生从习惯开始 卫生间常见的致癌习惯
已经有10人回复
- 【讨论】搞合成的做肿瘤药的前景
已经有33人回复
- 【资源】当乳腺癌发生转移时，肿瘤生物特性如ER,PR,HER2可能发生改变
已经有5人回复
- 【求助/交流】PI法 细胞周期 细胞凋亡
已经有10人回复
|
MicriRNA-29对肝细胞癌凋亡、致瘤性和预后的影响 基于微阵列资料，我们以前研究发现miR-29在肝细胞癌中明显下调。到目前为止，miR-29失调在肝细胞癌中作用，miR-29发挥作用和调控肝细胞癌细胞恶性表型的信号通路还不清楚。在该项研究中，我们应用Northern blot和实时定量RT-PCR方法证实miR-29低表达是肝细胞癌组织中一个常见的事件。比较有兴趣的是，miR-29下调明显与HCC病人无疾病生存差明显相关。功能获得和丧失研究显示miR-29可能是通过饥饿、缺氧或化疗药物触发了HCC细胞发生凋亡，这模拟了肿瘤体内生长环境和临床治疗。而且，miR-29可显著抑制HCC 细胞在裸鼠形成肿瘤的能力。随后的研究发现2种凋亡分子bcl-2和Mcl-1可作为miR-29的直接靶点。而且，沉默bcl-2和Mcl-1表型模拟了miR-29的前凋亡效应，而这些蛋白的过表达则消弱了miR-29效应。另外，miE-29增强的表达可导致线粒体潜能的丧失和细胞色素c释放到胞质中，提示miR-29可通过涉及Mcl-1和Bcl-2的线粒体途径而促进凋亡。结论：我们的资料表明miR-29在HCC凋亡调控和分子病因中的重要作用，提示miR-29在癌症的预后预测和治疗中潜在的作用。 |
2楼2010-07-29 21:37:06
